A novel strategy for reducing phospholipids-based matrix effect in LC-ESI-MS bioanalysis by means of HybridSPE

Vincenzo Pucci1, Serena Di Palma, Anna Alfieri

  • 1Department of Drug Metabolism and Pharmacokinetics, Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA. vincenzo pucci@merck.com